Finally, a tool to predict response to chemotherapy before bladder cancer surgery

University of Colorado Cancer Center led clinical trial data show that a predictive tool called COXEN may show which bladder cancer patients will respond to pre-surgical chemotherapy, a step towards allowing doctors to offer such chemotherapy to patients likely to respond, while moving more efficiently to other treatment options with patients unlikely to benefit. Results will be presented Monday, June 3 at 8:00am as oral abstract at the 2019 American Society for Clinical Oncology (ASCO) Annual Meeting (ASCO abstract #4506).

* This article was originally published here

Report: Huawei cuts meetings with US, sends US workers home

The Financial Times reported Friday that tech giant Huawei has ordered its employees to cancel technical meetings with American contacts and has sent home numerous U.S. employees working at its Chinese headquarters.

* This article was originally published here

More opioids given than prescribed in emergency department

(HealthDay)—The rate of emergency department visits with opioids only given during the visit is higher than the rate for visits with opioids only prescribed at discharge and for visits with opioids given and prescribed, according to a May data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.

* This article was originally published here

North Korea swine flu outbreak puts South on edge

South Korean troops stationed along the world's last Cold War frontier have been put on high alert in the face of a new infiltration threat from the nuclear-armed North—fever-stricken wild boar.

* This article was originally published here

A deep neural network that can maximize or minimize coloring to blend into or stand out against a background

A team of researchers at the University of Bristol has developed a deep learning neural network that can identify the best way to minimize or maximize coloring to allow for blending into a background or standing out. In their paper published in Journal of the Royal Society Interface, the team describes their network and possible uses for it.

* This article was originally published here

Physicists create stable, strongly magnetized plasma jet in laboratory

When you peer into the night sky, much of what you see is plasma, a soupy amalgam of ultra-hot atomic particles. Studying plasma in the stars and various forms in outer space requires a telescope, but scientists can recreate it in the laboratory to examine it more closely.

* This article was originally published here

Wrong side surgical errors substantially underreported and totally preventable

Performing a procedure on the wrong side of a patient's body, although rare, may be more common than generally thought. More than 80 wrong side error (WSE) incidents were reported across 100 hospitals in Spain over the past decade, according to new research being presented at this year's Euroanaesthesia Congress (the annual meeting of the European Society of Anaesthesiology) in Vienna, Austria (1-3 June).

* This article was originally published here

Trial of metformin for non-small cell lung cancer

Initial results of NRG-LU001 indicate that, although the diabetes agent metformin was well-tolerated by patients, the agent has not clearly improved progression-free survival (PFS) or overall survival (OS) for trial participants with locally advanced non-small cell lung cancer (NSCLC). These results are based on local center reported outcomes. Trial participants will continue to be followed for changes in their status. The initial report of these results were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and the abstract was awarded a "Best of ASCO" designation.

* This article was originally published here